Avanos Medical AVNS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 50%-4.6pp | 50.5%-5.0pp | 52.3%-3.2pp | 53.8%-2.0pp | 54.6%-1.7pp | |
| Operating margin | -9.1%+47.4pp | -9.1%+48.5pp | -69%-73.9pp | -68%-71.3pp | -56.6%-58.7pp | |
| Net margin | -10.4%— | -10.4%— | -67%— | —— | —— | |
| EBITDA margin | -3.6%+46.6pp | -3.6%+47.4pp | -63.2%-74.9pp | -61.8%-71.8pp | -50.2%-59.0pp | |
| Free cash flow margin | 1.6%-14.9pp | 6.7%-5.3pp | 11.3%+5.9pp | 13.3%+7.2pp | 16.5%+14.6pp | |
| Returns | ||||||
| Return on equity | -9.2%— | -9.1%— | -46.7%— | —— | —— | |
| Return on assets | -6.9%— | -6.5%— | -34.4%— | —— | —— | |
| Return on invested capital | -7.5%+27.1pp | -7.5%+27.7pp | -44.2%-46.6pp | -43.4%-45.0pp | -34.7%-35.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.2× | 0.6×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.5×+0.1× | |
| Inventory turnover | 2.6×+0.5× | 2.4×+0.4× | 2.1×+0.2× | 2.1×+0.2× | 2.1×+0.4× | |
| Liquidity | ||||||
| Current ratio | 2.5×-0.1× | 2.2×-0.2× | 2.4×+0.2× | 2.6×+0.4× | 2.6×+0.3× | |
| Quick ratio | 1.4×-0.2× | 1.3×-0.3× | 1.4×-0.1× | 1.6×+0.1× | 1.6×+0.1× | |
| Cash ratio | 0.5×-0.2× | 0.5×-0.1× | 0.5×+0.1× | 0.7×+0.2× | 0.7×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -9.1×+25.7× | -8.2×+24.3× | -55.5×-58.1× | -46.6×-48.2× | -34.8×-35.8× | |
| Per Share | ||||||
| Book value per share | $16.47-8.2% | $16.81-6.7% | $16.77-36.5% | $16.77-36.5% | $17.94-31.8% | |
| Valuation | ||||||
| Market capitalization | $1.17B+108% | $521.28M-28.8% | $536.41M-51.4% | $572.5M-37.4% | $659.23M-28.3% | |
| Enterprise value | $1.24B+105% | $560.58M-29.4% | $599.61M-50.7% | $619.5M-40.5% | $703.13M-33.6% | |
| Price / sales | 1.6×+0.8× | 0.7×-0.3× | 0.8×-0.9× | 0.8×-0.5× | 1×-0.4× | |
| Price / book | 1.5×+0.8× | 0.7×-0.2× | 0.7×-0.2× | 0.7×0.0× | 0.8×0.0× | |
| EV / sales | 1.7×+0.9× | 0.8×-0.4× | 0.9×-0.9× | 0.9×-0.6× | 1×-0.5× | |
| Free cash flow yield | 1%-19.3pp | 9.1%-2.3pp | 14.7%+11.4pp | 16.1%+11.5pp | 17.3%+15.8pp | |
| Earnings yield | -6.4%+62.1pp | -14%— | -87.4%— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Avanos Medical's profit margins?
- Avanos Medical (AVNS) runs a 50.0% gross margin and a -9.1% operating margin, with a -10.4% net margin.
- Where do Avanos Medical's ratios come from?
- Every ratio is computed from Avanos Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
